Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Animal drugs industry 3600 synopsis, 2018 - 2032
2.2 Business trends
2.2.1 Product trends
2.2.2 Animal type trends
2.2.3 Route of administration trends
2.2.4 Distribution channel trends
2.2.5 Regional trends
Chapter 3 Animal Drugs Industry Insights
3.1 Industry landscape, 2018 – 2032 (USD Million)
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Surging demand for pet insurance policies
3.2.1.2 Rising rate of obesity in companion animals
3.2.1.3 Increasing government support for pet care
3.2.1.4 Growing demand for online veterinary pharmacies
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost associated with animal drugs
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By animal type
3.3.3 By route of administration
3.3.4 By distribution channel
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.5.3 Asia Pacific
3.5.3.1 Japan
3.5.3.2 China
3.6 Policy landscape
3.7 Product pipeline analysis
3.8 Investor overview
3.9 Gap analysis
3.10 Porter’s analysis
3.11 PESTEL analysis
Chapter 4 Competitive Landscape, 2021
4.1 Introduction
4.2 Company matrix analysis, 2021
4.3 Strategy dashboard, 2021
Chapter 5 Animal Drugs Market, By Product
5.1 Key product trends
5.2 Drugs
5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.2 Antiparisitic
5.2.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.3 Anti-inflammatory
5.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.4 Anti-infectives
5.2.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.5 Others
5.2.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3 Vaccines
5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.2 Modified Live Vaccines (MLV)
5.3.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.3 Killed Inactivated Vaccines
5.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.4 Others
5.3.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4 Medicated Feed Additives
5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.2 Antibiotics
5.4.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.3 Vitamins
5.4.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.4 Enzymes
5.4.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.5 Antioxidants
5.4.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.6 Prebiotics and probiotics
5.4.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.7 Minerals
5.4.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.8 Others
5.4.8.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 6 Animal Drugs Market, By Animal Type
6.1 Key animal type trends
6.2 Livestock animals
6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.2.2 Poultry
6.2.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.2.3 Swine
6.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.2.4 Cattle
6.2.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.2.5 Fish
6.2.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.2.6 Others
6.2.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 Companion animals
6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3.2 Dogs
6.3.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3.3 Cats
6.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3.4 Horses
6.3.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3.5 Others
6.3.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 7 Animal Drugs Market, By Route of Administration
7.1 Key segment trends
7.2 Oral
7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3 Injectable
7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.4 Topical
7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.5 Others
7.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 8 Animal Drugs Market, By Distribution Channel
8.1 Key segment trends
8.2 Veterinary Hospitals
8.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.3 Veterinary Clinics
8.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.4 Pharmacy and Drug Stores
8.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.5 e-commerce
8.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 9 Animal Drugs Market, By Region
9.1 Key regional trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Poland
9.3.7 The Netherlands
9.4 Asia Pacific
9.4.1 China
9.4.2 India
9.4.3 Japan
9.4.4 Australia
9.4.5 South Korea
9.4.6 Taiwan
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.6 Middle East & Africa
9.6.1 South Africa
9.6.2 GCC Countries
9.6.3 Israel
Chapter 10 Company Profiles
10.1 Elanco Animal Health
10.2 Boehringer Ingelheim International GmbH
10.3 Ceva Sante Animale
10.4 Dechra Pharmaceuticals Ltd
10.5 Durvet, Inc.
10.6 Merck & Co., Inc
10.7 Neogen Corporation, Inc
10.8 Virbac S.A.
10.9 Vetoquinol SA
10.10 Zoetis, Inc.
